H.C. Wainwright slashed its price target to $0, assigning a 'Sell' rating and saying Sarepta has no remaining intrinsic value ...

Verizon Communications helped lead the way and rose 4%. The telecom giant reported a stronger profit for the latest quarter than analysts expected, along with higher revenue than forecast. Following ...

Defying the agency, Sarepta said it would continue to ship the therapy to ambulatory patients ... ago for walking patients ...